Global Transfection Technologies Market By Type (Lipofection, Electroporation, and Nucleofection), By Application (Research Centers & Academic/Government Institutes, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- Published date: Aug 2022
- Report ID: 37500
- Number of Pages: 310
- Format:
- keyboard_arrow_up
The report on Transfection Technologies Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transfection technologies market is segmented on the basis of type, application, and geography.
The Global Transfection Technologies market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.
Transfection Technologies Market Scope:
By type, the market is segmented into Lipofection, Electroporation, and Nucleofection. By application, the market is divided into Research Centers & Academic/Government Institutes, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bio-Rad, Polyplus Transfection, MaxCyte, Promega Corporation, Thermo Fisher Scientific, Affymetrix, Agilent Technologies, Altogen Biosystems, Boca Scientific, Chemicell, CytoPulse, Clontech, Deliverics, GE Healthcare Life Sciences, IBA GmbH, Lonza, Inovio Pharmaceuticals, Merck KGaA, Miltenyi Biotec, and Oz Biosciences.
Key Market Segments
Type
- Lipofection
- Electroporation
- Nucleofection
Application
- Research Centers & Academic/Government Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
Key Market Players included in the report:
- Bio-Rad
- Polyplus Transfection
- MaxCyte
- Promega Corporation
- Thermo Fisher Scientific
- Affymetrix
- Agilent Technologies
- Altogen Biosystems
- Boca Scientific
- Chemicell
- CytoPulse
- Clontech
- Deliverics
- GE Healthcare Life Sciences
- IBA GmbH
- Lonza
- Inovio Pharmaceuticals
- Merck KGaA
- Miltenyi Biotec
- Oz Biosciences
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Transfection Technologies Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Transfection Technologies Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Transfection Technologies Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transfection Technologies Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Transfection Technologies Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
- To know the Transfection Technologies Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Transfection Technologies sub-markets, depending on key regions (various vital states).
- To analyze Transfection Technologies Market concerning growth trends, prospects, and also their participation in the entire sector.
- To examine and study the Transfection Technologies Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2014 to 2019, and also prediction to 2028.
- Primary worldwide Transfection Technologies Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Transfection Technologies Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Transfection Technologies MarketPublished date: Aug 2022add_shopping_cartBuy Now get_appDownload Sample - Bio-Rad Laboratories, Inc. Company Profile
- Polyplus Transfection
- MaxCyte
- Promega Corporation
- Thermo Fisher Scientific Company Profile
- Affymetrix
- Agilent Technologies Inc. Company Profile
- Altogen Biosystems
- Boca Scientific
- Chemicell
- CytoPulse
- Takara Holdings Inc. (Takara Bio USA, Inc.) Company Profile
- Deliverics
- GE Healthcare Life Sciences
- IBA GmbH
- Lonza Group AG Company Profile
- Inovio Pharmaceuticals
- Merck KGaA Company Profile
- Miltenyi Biotec
- Oz Biosciences
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |